文献速递中医内科针灸推拿中药与中成药合理使用

中药干预靶向Wnt/β-catenin信号通路治疗脑缺血再灌注损伤综述

Traditional Chinese medicine interventions targeting Wnt/β-catenin signaling in cerebral ischemia/reperfusion injury: a review.
PubMed 文献 · Front Pharmacol · 2026-08-04

脑缺血再灌注损伤(CIRI)是血管再通治疗后的常见继发性神经损害,经典Wnt/β-catenin通路参与调控细胞存活、血管稳态、炎症平衡与神经再生。本文综述中药活性成分、复方及针灸通过抑制GSK-3β、稳定β-catenin并促其核转位激活该通路,发挥抗凋亡、保护血脑屏障、抗炎抗氧化及促神经发生与血管新生等神经保护作用的实验证据,并讨论向临床转化面临的局限与前景。

要点

  • Wnt/β-catenin通路是CIRI神经保护的有前景靶点。
  • 中药可经抑制GSK-3β、稳定β-catenin及促核转位激活该通路。
  • 中药多靶点调控与CIRI复杂病理特征相契合。

核心结论

  • 中药干预靶向Wnt/β-catenin通路可通过多环节发挥CIRI神经保护作用,为缺血性卒中中西医精准整合干预及新型神经保护剂研发提供理论依据。

研究设计与样本

  • 本文为综述,系统阐明Wnt/β-catenin信号参与CIRI损伤与修复的分子机制,并汇总中药干预靶向该通路的实验证据与作用规律。

主要发现

  • 中药干预可抑制GSK-3β活性、稳定β-catenin并促进其核转位,从而激活Wnt/β-catenin通路。
  • 激活该通路后可产生抗凋亡、保护血脑屏障、抗炎、抗氧化及促进神经发生与血管新生等多重效应。
  • 中药包括草药来源活性化合物、复方及针灸,具有多靶点调控优势,与CIRI复杂病理特征相契合。

临床怎么用

  • 现有证据来自基础实验,临床可将Wnt/β-catenin通路作为理解中药神经保护作用机制的参考框架。
  • 临床决策仍需结合循证证据,不宜直接依据本综述的实验结论改变用药或针灸方案。

局限性

  • 综述指出当前中药靶向该通路的研究在向临床应用转化方面仍存在局限,具体局限内容原文未逐条列明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vascular recanalization therapy for ischemic stroke commonly induces cerebral ischemia-reperfusion injury (CIRI), which causes secondary neural damage and substantially limits clinical benefit. The canonical Wnt/β-catenin signaling pathway has a central role in regulating central nervous system cell survival, vascular homeostasis, inflammatory balance, and neuroregeneration, making it a highly promising neuroprotective target for CIRI. Traditional Chinese medicine (TCM), including herbal-derived active compounds, compound formulas, and acupuncture, has distinctive multitarget regulatory advantages that are well aligned with the complex pathological features of CIRI. Existing basic studies indicate that TCM interventions can activate this pathway by inhibiting GSK-3β activity, stabilizing β-catenin, and promoting its nuclear translocation, thereby exerting multiple effects, including anti-apoptotic activity, blood-brain barrier (BBB) protection, anti-inflammatory and antioxidant actions, and promotion of neurogenesis and angiogenesis. This review systematically elucidates the molecular mechanisms by which Wnt/β-catenin signaling participates in CIRI-induced injury and repair, comprehensively summarizes the experimental evidence and action patterns of TCM interventions targeting this pathway for neuroprotection, and discusses the current limitations and future prospects for translating basic research into clinical application. This review aims to provide a solid theoretical basis for precision integrated Chinese-Western interventions in ischemic stroke and for the development of new neuroprotective agents.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wu Y, Sun Y, Song Y, et al. Traditional Chinese medicine interventions targeting Wnt/β-catenin signaling in cerebral ischemia/reperfusion injury: a review. Front Pharmacol. 2026. PMID: 42614252. doi:10.3389/fphar.2026.1902090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。